Exome-wide association studies and genome-wide association studies have identified that the TM6SF2 variant (encoding p. Glu167Lys, E167K) is associated with decreased myocardial infarction risk and increased fatty liver disease [26,27]. Here, TM6SF2 is linked to myocardial infarction.